Used as a key intermediate in the synthesis of selective cannabinoid receptor modulators, particularly in the development of pharmaceuticals targeting CB1 and CB2 receptors for pain management, neuroinflammatory conditions, and neurological disorders. Its stereochemistry enables high receptor specificity, making it valuable in creating potent and selective therapeutic agents. Also employed in structure-activity relationship (SAR) studies to optimize cannabinoid ligand efficacy and metabolic stability.